发明授权
US07829587B2 Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
有权
取代的2-氨基四氢萘衍生物作为选择性α2B激动剂
- 专利标题： Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
- 专利标题（中）： 取代的2-氨基四氢萘衍生物作为选择性α2B激动剂
-
申请号： US11971828申请日： 2008-01-09
-
公开(公告)号： US07829587B2公开(公告)日： 2010-11-09
- 发明人: John R. Cappiello , Dario G. Gomez , Ken Chow , Michael E. Garst , Daniel W. Gil , Larry A. Wheeler
- 申请人： John R. Cappiello , Dario G. Gomez , Ken Chow , Michael E. Garst , Daniel W. Gil , Larry A. Wheeler
- 申请人地址： US CA Irvine
- 专利权人： Allergan, Inc.
- 当前专利权人： Allergan, Inc.
- 当前专利权人地址： US CA Irvine
- 代理商 Doina G. Ene; John E. Wurst; Kevin J. Forrestal
- 主分类号： C07D213/04
- IPC分类号： C07D213/04 ; A61K31/4402
摘要：
Substituted 2-aminotetralin derivatives as selective alpha 2B agonists can be incorporated in a pharmaceutical composition and can be used in methods of treating an alpha 2B receptor mediated diseases or conditions. The compounds are represented by Formula 1: wherein R1=H, methyl, ethyl, propyl, or cyclobutyl; R2=methyl or H; R3=pyridinyl X=C or O.
公开/授权文献
信息查询
